Entering text into the input field will update the search result below

Neuronetics' (STIM) CEO Chris Thatcher on Q4 2019 Results - Earnings Call Transcript

Mar. 03, 2020 1:52 PM ETNeuronetics, Inc. (STIM)
SA Transcripts profile picture
SA Transcripts

Neuronetics Inc. (NASDAQ:STIM) Q4 2019 Earnings Conference Call March 3, 2020 8:30 AM ET

Company Participants

Mark Klausner – Westwicke Partners, LLC-Managing Partner

Chris Thatcher – Chief Executive Officer

Steve Furlong – Chief Financial Officer

Conference Call Participants

Malgorzata Kaczor – William Blair

Dave Turkaly – JMP Securities


Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter and Full Year 2019 Financial and Operating Results Conference Call. At this time, all participants’ lines are in a listen-only mode. After speakers’ presentation, there'll be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]

I will now hand the conference call over to your speaker today, Mark Klausner. Thank you, and please go ahead, sir.

Mark Klausner

Thank you, operator. Good morning, and thank you for joining us for Neuronetics fourth quarter and full year 2019 conference call. A replay of this call will be available on our website for 30 days.

Joining me on today's call are Neuronetics' Chief Executive Officer, Chris Thatcher; and its Chief Financial Officer, Steve Furlong.

Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements related to our business, strategy, financial and revenue guidance and other operational issues and metrics. Actual results could differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business.

For a discussion of risks and uncertainties associated with Neuronetics' business, I encourage you to review the company's filings with the Securities and Exchange Commission, including the company's annual report on Form 10-K expected to be filed later today. The company disclaims any

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.